New hope for burn survivors: drug may stop unbearable itching
Symptom relief
Recruiting now
This study tests if Dupixent can reduce severe itching in adults with burn scars that don't respond to standard treatments. About 46 people aged 18-60 will receive either Dupixent or a placebo for 12 weeks. The goal is to see if itching scores drop significantly more with Dupixen…
Phase: PHASE2 • Sponsor: Akron Children's Hospital • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC